Search Results - "Angellier, E."

1118 A cancer can hide another: Survey of a cohort by Angellier, E, De Vaugelade, C

Get full text

Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study by Piedbois, P., Serin, D., Priou, F., Laplaige, P., Greget, S., Angellier, E., Teissier, E., Berdah, J.-F., Fabbro, M., Valenza, B., Herait, P., Jehl, V., Buyse, M.

“…Background: Adding a taxane to anthracycline-based adjuvant chemotherapy prolongs survival in node-positive patients but optimal dose and schedule remain…”
Get full text

Encéphalopathie aiguë fatale secondaire à un traitement par 5-fluoro-uracile by Mémain, N., Angellier, J.-F., Obadia, E., Angellier, E., Chelha, R., Couprie, R.

“…Les encéphalopathies au 5-fluoro-uracile (5FU) sont rares et d’évolution habituellement régressive. Une femme de 45 ans traitée par une chimiothérapie…”
Get full text

Acute cutaneous reactions induced by docetaxel: a case report by Talla, M, Mangold, M, Angellier, E, Salemkour, A, Desprez-Curely, J M, Zerrouk, N

Get more information

Analysis of the impact of growth factor on the haematological safety of dose-dense regimen in the randomized phase II adjuvant trial BO3 by Delbaldo, C., Serin, D., Priou, F., Laplaige, P., Greget, S., Angellier, E., Teissier, E., Berdah, J., Fabbro, M., Quinaux, E.

“…Abstract only 605 Background: In a randomized phase II study, P. Piedbois et al. explored a dose-dense docetaxel (T) followed by epirubicin/cyclophosphamide…”
Get full text

Hormone therapy and breast cancer: a review by Lucchi-Angellier, E

“…Tamoxifen as adjuvant hormonal therapy after hormonosensitive-breast cancer surgery is well established nowadays, as well as its efficacy in first-line therapy…”
Get full text

Patients' rights during medical research and specifics in oncology (in France) by Lucchi-Angellier, E

“…Clinical research in oncology is part of the care, instead of being theoretical, because it can offer new drugs to patients who are suffering from severe…”
Get full text

AERO-B03: A randomized phase II trial of dose-dense docetaxel in node-positive breast cancer by Piedbois, P.-P., Serin, D., Priou, F., Laplaige, P., Greget, S., Angellier, E., Teissier, E., Berdah, J. F., Fabbro, M., Valenza, B.

“…Abstract only…”
Get full text

Multicentric phase II study of epirubicin and docetaxel as first line treatment for patients with advanced gastric cancer: A GERCOR study by Nguyen, S., Flesch, M., Bennamoun, M., Salle, F., Angellier, E., Carola, E., Berdah, J. F., Cattan, S., Magherini, E., Louvet, C.

“…Abstract only…”
Get full text

Multicentric phase II study of epirubicin and docetaxel as first line treatment for patients with advanced gastric cancer: A GERCOR study by Nguyen, S., Flesch, M., Bennamoun, M., Salle, F., Angellier, E., Carola, E., Berdah, J. F., Cattan, S., Magherini, E., Louvet, C.

“…Abstract only…”
Get full text

Fatal acute encephalopathy due to 5-fluorouracil treatment by Mémain, N, Angellier, J-F, Obadia, E, Angellier, E, Chelha, R, Couprie, R

“…Encephalopathies from 5 fluorouracil (5FU) are rare and generally resolve favorably. Six days after her first course of chemotherapy combining 5FU and…”
Get full text

Hormonothérapies et cancers du sein : mise au point by Lucchi-Angellier, E

“…Propos. – Le traitement hormonal adjuvant des cancers du sein hormonodépendants par tamoxifène est actuellement bien validé, de même que l’intérêt de cette…”
Get full text

Droit des personnes dans les études de recherche clinique et particularités de l’oncologie (en France) by Lucchi-Angellier, E

“…Propos. – Dans son principe, la recherche clinique en cancérologie est partie intégrante des soins. Elle peut permettre à des personnes atteintes de maladies…”
Get full text